关键词: Fetal Heart Methotrexate Pregnancies Tubal

Mesh : Female Pregnancy Humans Pregnancy, Tubal / diagnostic imaging therapy Pregnancy, Ectopic / surgery Methotrexate / therapeutic use Chorionic Gonadotropin, beta Subunit, Human Fetal Heart

来  源:   DOI:10.34763/jmotherandchild.20222601.d-22-00037

Abstract:
The incidence of ectopic pregnancy (EP) is 1.3-2.4%. Suspicion of EP starts after a positive serum pregnancy test and failure to visualize the intrauterine gestational sac (GS) by transvaginal sonography (TVS). About 88% of tubal EPs are diagnosed by absent intrauterine GS and the presence of an adnexal mass during TVS. Medical treatment of EP using methotrexate (MTX) is cost-effective with a similar success rate to surgical treatment. The presence of fetal heart beats, β-human chorionic gonadotropin >5000 mIU/mL, and EP size >4 cm are relative contraindications for using MTX in the treatment of EP.
摘要:
异位妊娠(EP)的发生率为1.3-2.4%。在血清妊娠试验阳性且无法通过经阴道超声检查(TVS)观察宫内孕囊(GS)后,开始怀疑EP。大约88%的输卵管EP是通过子宫内GS缺失和TVS期间附件肿块的存在而诊断的。使用甲氨蝶呤(MTX)进行EP的药物治疗具有成本效益,与手术治疗的成功率相似。胎儿心跳的存在,β-人绒毛膜促性腺激素>5000mIU/mL,和EP尺寸>4cm是使用MTX治疗EP的相对禁忌症。
公众号